Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
AimHypersensitivity pneumonitis (HP), also referred to as exogenous allergic alveolitis, is one of the most common interstitial lung diseases (ILDs). A potential immune biomarker, Krebs von den lgen-6 (KL-6) characterizes the progression and severity of HP. The meta-analysis in this study was conduc...
Main Authors: | Jie He, Jiangliu Zhang, Xinyi Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041098/full |
Similar Items
-
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
by: Noha Hosni Ibrahim, et al.
Published: (2023-11-01) -
Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
by: Myeong Geun Choi, et al.
Published: (2022-12-01) -
Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis
by: Takayuki Takimoto, et al.
Published: (2022-06-01) -
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
by: Vito D’Agnano, et al.
Published: (2022-07-01) -
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
by: Ivan Castellví, et al.
Published: (2022-08-01)